var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?d387e539c1f2d34f09a9afbac8032280"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })();
IBE/Amir Ghaiyoumi
Epilepsy accounts for a significant proportion of the world’s disease burden, affecting around 50 million people worldwide.
? Credits

Epilepsy

    Overview

    Epilepsy is the most common chronic brain disease and affects people of all ages. More than 50 million people worldwide have epilepsy; nearly 80% of them live in low- and middle-income countries.

    An estimated 70% of people with epilepsy could be seizure free if properly diagnosed and treated. However, about three quarters of people with epilepsy in low-income countries do not get the treatment they need, and this rises to 90% in some countries. In many such countries, many health professionals do not have the training to recognize, diagnose and treat epilepsy. In most resource-poor countries, anti-seizure medications are not available.

    People with epilepsy and their families frequently suffer from stigma and discrimination. In many parts of the world the true nature of epilepsy has also long been distorted by myths, fear and mistaken notions about the disorder.

    WHO is working with ministries of health and partners to improve access to treatment for epilepsy.

    WHO response

    66顺彩票appThe WHO Programme on Reducing the Epilepsy Treatment Gap combines several innovative strategies to support access and care to services for people with epilepsy, thereby reducing the epilepsy treatment gap. The Programme is currently being implemented in four countries – Ghana, Mozambique, Myanmar and Viet Nam – with hopes to expand implementation to all low- and middle-income countries

    Previous WHO collaborative programmes on epilepsy have shown that integrating epilepsy care in primary health care can significantly reduce the epilepsy treatment gap. Based on the evidence-based methods of the WHO Mental Health Gap Action Programme (mhGAP), WHO will support the training of primary care, non-specialist health care providers to diagnose, treat and follow up people with epilepsy. In the four pilot countries, the national health authorities have committed to the training of health care providers and integrating epilepsy care within their primary care systems.

    Stigma and discrimination prevent people with epilepsy from seeking treatment and from leading meaningful lives. The WHO Programme on Reducing the Epilepsy Treatment Gap seeks to mobilize NGOs and community groups to inform and engage communities on epilepsy, and to better support people with epilepsy and their families.

     


    50 million

    people

    worldwide have epilepsy

    Fact sheet

    3/4

    of people

    66顺彩票appwith epilepsy in low-income countries do not get treated

    Fact sheet

    US$ 5

    per year

    66顺彩票appcan provide effective medications to help a person live seizure free

    Fact sheet

    Publications

    All →
    mhGAP Intervention Guide - Version 2.0
    for mental, neurological and substance use disorders in non-specialized health settings
    Epilepsy: a public health imperative

    Epilepsy: a public health imperative is the first global report on epilepsy summarizing the available evidence on the burden of epilepsy and the public...

    ATLAS Country Resources for Neurological Disorders

    66顺彩票appThe second edition of the Neurology Atlas represents updated information on the status of neurological services and provision of neurological care from...

    Video

    963彩票开户 677彩票开户 7072彩票开户 66顺彩票总代理 7073彩票地址 689彩票邀请码 7073彩票网址 7073彩票登录 8炫彩彩票app 9188彩票代理